Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Breast Neoplasms"" wg kryterium: Temat


Tytuł :
Inhibition of YTHDF2 triggers proteotoxic cell death in MYC-driven breast cancer.
Autorzy :
Einstein JM; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Perelis M; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Chaim IA; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Meena JK; Verna & Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Nussbacher JK; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Tankka AT; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Yee BA; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Li H; Verna & Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Madrigal AA; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Neill NJ; Verna & Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Shankar A; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA.
Tyagi S; Verna & Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
Westbrook TF; Verna & Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX 77030, USA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA; Therapeutic Innovation Center (THINC), Baylor College of Medicine, Houston, TX 77030, USA.
Yeo GW; Department of Cellular and Molecular Medicine, University of California, San Diego, La Jolla, CA, USA; Stem Cell Program, University of California, San Diego, La Jolla, CA, USA; Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA. Electronic address: .
Pokaż więcej
Źródło :
Molecular cell [Mol Cell] 2021 Aug 05; Vol. 81 (15), pp. 3048-3064.e9. Date of Electronic Publication: 2021 Jul 02.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Breast Neoplasms/*genetics
Breast Neoplasms/*pathology
RNA-Binding Proteins/*genetics
Adenosine/analogs & derivatives ; Adenosine/metabolism ; Animals ; Cell Death/genetics ; Epithelial-Mesenchymal Transition/genetics ; Female ; Gene Expression Regulation, Neoplastic ; Genes, myc ; Humans ; Mice, Nude ; Mice, Transgenic ; Protein Biosynthesis ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/metabolism ; Triple Negative Breast Neoplasms/pathology ; Xenograft Model Antitumor Assays
Czasopismo naukowe
Tytuł :
Associated factors and outcomes of delaying adjuvant chemotherapy in breast cancer by biologic subtypes: a National Cancer Database study.
Autorzy :
Ashok Kumar P; Department of Internal Medicine, SUNY Upstate Medical University, Syracuse, NY, 13210, USA. .; Department of Internal Medicine, SUNY Upstate Medical University, 750 E Adams Street, Syracuse, NY, 13210, USA. .
Paulraj S; Department of Internal Medicine, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Wang D; Department of Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Huang D; Department of Public Health and Preventive Medicine, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Sivapiragasam A; Department of Hematology-Oncology, SUNY Upstate Medical University, Syracuse, NY, 13210, USA.
Pokaż więcej
Źródło :
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2021 Aug; Vol. 147 (8), pp. 2447-2458. Date of Electronic Publication: 2021 Jan 31.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Breast Neoplasms/*drug therapy
Breast Neoplasms/*pathology
Time-to-Treatment/*statistics & numerical data
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Breast Neoplasms/diagnosis ; Breast Neoplasms/mortality ; Breast Neoplasms, Male/diagnosis ; Breast Neoplasms, Male/drug therapy ; Breast Neoplasms, Male/mortality ; Breast Neoplasms, Male/pathology ; Chemotherapy, Adjuvant ; Databases, Factual ; Drug Administration Schedule ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Survival Analysis ; Time Factors ; Treatment Outcome ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł :
Expression and clinical implications of basic leucine zipper ATF-like transcription factor 2 in breast cancer.
Autorzy :
Lin Y; Laboratory of Biochemistry and Molecular Biology Research, Department of Clinical Laboratory, Fujian Medical University Cancer Hospital, No. 420 Fuma Road, Jin'an District, Fuzhou, 350014, Fujian Province, China.
Zhou X; Laboratory of Biochemistry and Molecular Biology Research, Department of Clinical Laboratory, Fujian Medical University Cancer Hospital, No. 420 Fuma Road, Jin'an District, Fuzhou, 350014, Fujian Province, China.
Peng W; Laboratory of Biochemistry and Molecular Biology Research, Department of Clinical Laboratory, Fujian Medical University Cancer Hospital, No. 420 Fuma Road, Jin'an District, Fuzhou, 350014, Fujian Province, China.
Wu J; Laboratory of Biochemistry and Molecular Biology Research, Department of Clinical Laboratory, Fujian Medical University Cancer Hospital, No. 420 Fuma Road, Jin'an District, Fuzhou, 350014, Fujian Province, China.
Wu X; Department of Breast Surgical Oncology, Fujian Medical University Cancer Hospital, Fuzhou, Fujian, China. .
Chen Y; Laboratory of Biochemistry and Molecular Biology Research, Department of Clinical Laboratory, Fujian Medical University Cancer Hospital, No. 420 Fuma Road, Jin'an District, Fuzhou, 350014, Fujian Province, China. .
Cui Z; Laboratory of Biochemistry and Molecular Biology Research, Department of Clinical Laboratory, Fujian Medical University Cancer Hospital, No. 420 Fuma Road, Jin'an District, Fuzhou, 350014, Fujian Province, China. .
Pokaż więcej
Źródło :
BMC cancer [BMC Cancer] 2021 Sep 26; Vol. 21 (1), pp. 1062. Date of Electronic Publication: 2021 Sep 26.
Typ publikacji :
Journal Article
MeSH Terms :
Basic-Leucine Zipper Transcription Factors/*metabolism
Breast Neoplasms/*metabolism
Neoplasm Proteins/*metabolism
Tumor Suppressor Proteins/*metabolism
BRCA2 Protein/metabolism ; Basic-Leucine Zipper Transcription Factors/blood ; Basic-Leucine Zipper Transcription Factors/genetics ; Breast/metabolism ; Breast Neoplasms/blood ; Breast Neoplasms/mortality ; Databases, Factual ; Exosomes/metabolism ; Female ; Humans ; Immunohistochemistry ; Ki-67 Antigen/metabolism ; Neoplasm Proteins/blood ; Neoplasm Proteins/genetics ; Prognosis ; RNA, Messenger/metabolism ; Receptors, Androgen/metabolism ; Tissue Array Analysis ; Triple Negative Breast Neoplasms/metabolism ; Triple Negative Breast Neoplasms/mortality ; Tumor Suppressor Protein p53/metabolism ; Tumor Suppressor Proteins/blood ; Tumor Suppressor Proteins/genetics
Czasopismo naukowe
Tytuł :
Association of body composition with odds of breast cancer by molecular subtype: analysis of the Mechanisms for Established and Novel Risk Factors for Breast Cancer in Nigerian Women (MEND) study.
Autorzy :
Akinyemiju T; Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC, USA. .; Duke Cancer Institute, School of Medicine, Duke University, Durham, NC, USA. .; Duke Global Health Institute, Duke University, Durham, NC, USA. .
Jones K; Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC, USA.
Gupta A; Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC, USA.; Trinity College of Arts and Sciences, Duke University, Durham, NC, USA.
Oyekunle T; Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC, USA.
Saraiya V; Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, USA.
Deveaux A; Department of Population Health Sciences, School of Medicine, Duke University, Durham, NC, USA.
Salako O; College of Medicine & Lagos University Teaching Hospital, University of Lagos, Lagos, Lagos State, Nigeria.
Hall A; Department of Pathology, School of Medicine, Duke University, Durham, NC, USA.
Alatise O; Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria.
Ogun G; University College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria.
Adeniyi A; Federal Medical Center, Abeokuta, Ogun State, Nigeria.
Ayandipo O; University College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria.
Olajide T; College of Medicine & Lagos University Teaching Hospital, University of Lagos, Lagos, Lagos State, Nigeria.
Olasehinde O; Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria.
Arowolo O; Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria.
Adisa A; Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun State, Nigeria.
Afuwape O; University College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria.
Olusanya A; University College Hospital, University of Ibadan, Ibadan, Oyo State, Nigeria.
Adegoke A; Our Lady of Apostle Catholic Hospital, Ibadan, Oyo State, Nigeria.
Tollefsbol TO; University of Alabama at Birmingham, Birmingham, AL, USA.
Arnett D; University of Kentucky, Lexington, KY, USA.
Daramola A; College of Medicine & Lagos University Teaching Hospital, University of Lagos, Lagos, Lagos State, Nigeria.
Pokaż więcej
Corporate Authors :
H3 Africa Kidney Research Network
Źródło :
BMC cancer [BMC Cancer] 2021 Sep 25; Vol. 21 (1), pp. 1051. Date of Electronic Publication: 2021 Sep 25.
Typ publikacji :
Journal Article
MeSH Terms :
Body Composition*
Breast Neoplasms/*etiology
Adult ; Body Height ; Body Mass Index ; Body Weight ; Breast Neoplasms/chemistry ; Case-Control Studies ; Confidence Intervals ; Female ; Humans ; Menopause ; Middle Aged ; Nigeria ; Odds Ratio ; Reproductive History ; Risk Factors ; Triple Negative Breast Neoplasms/chemistry ; Triple Negative Breast Neoplasms/etiology
Czasopismo naukowe
Tytuł :
Automated segmentation and tracking of mitochondria in live-cell time-lapse images.
Autorzy :
Lefebvre AEYT; Department of Biomedical Engineering, University of California, Irvine, Irvine, CA, USA.; Laboratory for Fluorescence Dynamics, Irvine, CA, USA.
Ma D; Department of Biological Chemistry, University of California, Irvine, Irvine, CA, USA.
Kessenbrock K; Department of Biological Chemistry, University of California, Irvine, Irvine, CA, USA.
Lawson DA; Department of Physiology and Biophysics, University of California, Irvine, Irvine, CA, USA.
Digman MA; Department of Biomedical Engineering, University of California, Irvine, Irvine, CA, USA. .; Laboratory for Fluorescence Dynamics, Irvine, CA, USA. .
Pokaż więcej
Źródło :
Nature methods [Nat Methods] 2021 Sep; Vol. 18 (9), pp. 1091-1102. Date of Electronic Publication: 2021 Aug 19.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Mitochondria*/metabolism
Software*
Breast Neoplasms/*pathology
Imaging, Three-Dimensional/*methods
Time-Lapse Imaging/*methods
Algorithms ; Breast Neoplasms/metabolism ; Cells, Cultured ; Female ; Humans ; Mammary Glands, Human/cytology ; NAD/metabolism ; Reproducibility of Results ; Triple Negative Breast Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines.
Autorzy :
Andreidesz K; Department of Biochemistry and Medical Chemistry, University of Pecs Medical School, 7624 Pecs, Hungary.
Szabo A; Department of Biochemistry and Medical Chemistry, University of Pecs Medical School, 7624 Pecs, Hungary.
Kovacs D; Department of Biochemistry and Medical Chemistry, University of Pecs Medical School, 7624 Pecs, Hungary.
Koszegi B; Department of Biochemistry and Medical Chemistry, University of Pecs Medical School, 7624 Pecs, Hungary.
Bagone Vantus V; Department of Biochemistry and Medical Chemistry, University of Pecs Medical School, 7624 Pecs, Hungary.
Vamos E; Department of Biochemistry and Medical Chemistry, University of Pecs Medical School, 7624 Pecs, Hungary.
Isbera M; Institute of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Pecs, 7624 Pecs, Hungary.
Kalai T; Institute of Organic and Medicinal Chemistry, Faculty of Pharmacy, University of Pecs, 7624 Pecs, Hungary.; Szentagothai Research Centre, University of Pecs, 7624 Pecs, Hungary.
Bognar Z; Department of Biochemistry and Medical Chemistry, University of Pecs Medical School, 7624 Pecs, Hungary.
Kovacs K; Department of Biochemistry and Medical Chemistry, University of Pecs Medical School, 7624 Pecs, Hungary.
Gallyas F Jr; Department of Biochemistry and Medical Chemistry, University of Pecs Medical School, 7624 Pecs, Hungary.; Szentagothai Research Centre, University of Pecs, 7624 Pecs, Hungary.; HAS-UP Nuclear-Mitochondrial Interactions Research Group, 1245 Budapest, Hungary.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Aug 20; Vol. 22 (16). Date of Electronic Publication: 2021 Aug 20.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms/*drug therapy
Cytostatic Agents/*pharmacology
Mitochondria/*drug effects
Nitrogen Oxides/*pharmacology
Pyrroles/*pharmacology
Apoptosis/drug effects ; Breast Neoplasms/metabolism ; Cell Line, Tumor ; Cell Proliferation/drug effects ; Cell Survival/drug effects ; Female ; Humans ; MCF-7 Cells ; Membrane Potential, Mitochondrial/drug effects ; Mitochondrial Membranes/drug effects ; Reactive Oxygen Species/metabolism ; Triple Negative Breast Neoplasms/drug therapy ; Triple Negative Breast Neoplasms/metabolism
Czasopismo naukowe
Tytuł :
Epithelial Mesenchymal Transition and Immune Response in Metaplastic Breast Carcinoma.
Autorzy :
González-Martínez S; Clinical Researcher, Hospital Ramón y Cajal, 28034 Madrid, Spain.
Pérez-Mies B; Department of Pathology, Hospital Ramón y Cajal, 28034 Madrid, Spain.; Institute Ramón y Cajal for Health Research (IRYCIS), 28034 Madrid, Spain.; CIBER-ONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.; Faculty of Medicine, University of Alcalá de Henares, Alcalá de Henares, 28801 Madrid, Spain.
Pizarro D; Institute Ramón y Cajal for Health Research (IRYCIS), 28034 Madrid, Spain.
Caniego-Casas T; Institute Ramón y Cajal for Health Research (IRYCIS), 28034 Madrid, Spain.
Cortés J; CIBER-ONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, 28670 Madrid, Spain.; International Breast Cancer Center (IBCC), Quironsalud Group, 08017 Barcelona, Spain.; Medica Scientia Innovation Research, 08007 Barcelona, Spain.; Medica Scientia Innovation Research, Ridgewood, NJ 07450, USA.; Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.
Palacios J; Department of Pathology, Hospital Ramón y Cajal, 28034 Madrid, Spain.; Institute Ramón y Cajal for Health Research (IRYCIS), 28034 Madrid, Spain.; CIBER-ONC, Instituto de Salud Carlos III, 28029 Madrid, Spain.; Faculty of Medicine, University of Alcalá de Henares, Alcalá de Henares, 28801 Madrid, Spain.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Jul 09; Vol. 22 (14). Date of Electronic Publication: 2021 Jul 09.
Typ publikacji :
Journal Article; Review
MeSH Terms :
B7-H1 Antigen/*metabolism
Breast Neoplasms/*drug therapy
Breast Neoplasms/*immunology
Carcinoma/*immunology
Carcinoma/*metabolism
Epithelial-Mesenchymal Transition/*immunology
B7-H1 Antigen/immunology ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/immunology ; Biomarkers, Tumor/metabolism ; Breast Neoplasms/genetics ; Breast Neoplasms/metabolism ; Cadherins/metabolism ; Carcinoma/drug therapy ; Carcinoma/genetics ; Epithelial-Mesenchymal Transition/drug effects ; Epithelial-Mesenchymal Transition/genetics ; Female ; Humans ; Lymphocytes, Tumor-Infiltrating/immunology ; MicroRNAs/genetics ; MicroRNAs/metabolism ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/immunology ; Triple Negative Breast Neoplasms/metabolism ; Triple Negative Breast Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Identify the triple-negative and non-triple-negative breast cancer by using texture features of medicale ultrasonic image: A STROBE-compliant study.
Autorzy :
Chen Q; Department of Ultrasonography.
Xia J; Department of Radiology.
Zhang J; Department of Nuclear Medicine, Taizhou people's Hospital affiliated to Medical College of Yangzhou University Taizhou, China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 Jun 04; Vol. 100 (22), pp. e25878.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Breast Neoplasms/*diagnostic imaging
Breast Neoplasms/*pathology
Image Processing, Computer-Assisted/*methods
Ultrasonography/*methods
Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/surgery ; Female ; Humans ; Middle Aged ; ROC Curve ; Retrospective Studies ; Triple Negative Breast Neoplasms/diagnostic imaging ; Triple Negative Breast Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Clinical practice of breast cancer protontherapy: A single-centre experience from selection to treatment.
Autorzy :
Loap P; Department of radiation oncology, Institut Curie, Paris, France.
Beddok A; Department of radiation oncology, Institut Curie, Paris, France.
Cao KI; Department of radiation oncology, Institut Curie, Paris, France.
Goudjil F; Department of radiation oncology, Institut Curie, Paris, France.
Fourquet A; Department of radiation oncology, Institut Curie, Paris, France.
Dendale R; Department of radiation oncology, Institut Curie, Paris, France.
Kirova Y; Department of radiation oncology, Institut Curie, Paris, France. Electronic address: .
Pokaż więcej
Źródło :
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [Cancer Radiother] 2021 Jun; Vol. 25 (4), pp. 358-365. Date of Electronic Publication: 2021 Mar 03.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Proton Therapy*/statistics & numerical data
Breast Neoplasms/*radiotherapy
Adult ; Age Factors ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Breast Neoplasms/drug therapy ; Breast Neoplasms/genetics ; Breast Neoplasms/surgery ; Cardiotoxicity/prevention & control ; Female ; France ; Genes, BRCA1 ; Humans ; Mutation ; Patient Selection ; Radiation Injuries/prevention & control ; Radiotherapy, Adjuvant/statistics & numerical data ; Radiotherapy, Intensity-Modulated ; Re-Irradiation ; Retrospective Studies ; Triple Negative Breast Neoplasms/drug therapy ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/radiotherapy ; Triple Negative Breast Neoplasms/surgery ; Unilateral Breast Neoplasms/drug therapy ; Unilateral Breast Neoplasms/genetics ; Unilateral Breast Neoplasms/radiotherapy ; Unilateral Breast Neoplasms/surgery ; Young Adult
Czasopismo naukowe
Tytuł :
Conditional regional recurrence risk: The effect of event-free years in different subtypes of breast cancer.
Autorzy :
Vane MLG; Department of Surgical Oncology, Maastricht University Medical Centre, Maastricht, the Netherlands; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, the Netherlands. Electronic address: .
Moossdorff M; Department of Surgical Oncology, Maastricht University Medical Centre, Maastricht, the Netherlands.
van Maaren MC; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands; Department of Health, Technology and Services Research. Technical Medical Centre, University of Twente, Enschede, the Netherlands.
van Kuijk SMJ; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, the Netherlands.
van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
van Roozendaal LM; Department of Surgical Oncology, Maastricht University Medical Centre, Maastricht, the Netherlands.
Boerma EG; Department of Surgery, Zuyderland Hospital, Heerlen, the Netherlands.
de WIlt JHW; Department of Surgical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands.
Smidt ML; Department of Surgical Oncology, Maastricht University Medical Centre, Maastricht, the Netherlands; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, the Netherlands.
Pokaż więcej
Źródło :
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2021 Jun; Vol. 47 (6), pp. 1292-1298. Date of Electronic Publication: 2020 Nov 27.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms/*epidemiology
Breast Neoplasms/*pathology
Lymph Nodes/*pathology
Neoplasm Recurrence, Local/*epidemiology
Adult ; Aged ; Aged, 80 and over ; Breast Neoplasms/metabolism ; Female ; Humans ; Kaplan-Meier Estimate ; Lymphatic Metastasis ; Middle Aged ; Neoplasm Staging ; Netherlands/epidemiology ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Registries ; Risk Assessment ; Risk Factors ; Time Factors ; Triple Negative Breast Neoplasms/epidemiology ; Triple Negative Breast Neoplasms/pathology ; Young Adult
Czasopismo naukowe
Tytuł :
Identification of Hub Genes to Regulate Breast Cancer Spinal Metastases by Bioinformatics Analyses.
Autorzy :
He Y; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Cao Y; Trauma Orthopedic Department, Guizhou Provincial Orthopedics Hospital, No. 123 Shangchong South Road, Nanming District, Guiyang City, Guizhou Province, China.
Wang X; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Jisiguleng W; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Tao M; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Liu J; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Wang F; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Chao L; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Wang W; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Li P; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Fu H; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Xing W; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Zhu Z; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Huan Y; Department of Spine Surgery, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Yuan H; Department of Pathology, Inner Mongolia People's Hospital, Hohhot, 010017 Inner Mongolia, China.
Pokaż więcej
Źródło :
Computational and mathematical methods in medicine [Comput Math Methods Med] 2021 May 12; Vol. 2021, pp. 5548918. Date of Electronic Publication: 2021 May 12 (Print Publication: 2021).
Typ publikacji :
Journal Article
MeSH Terms :
Gene Regulatory Networks*
Breast Neoplasms/*genetics
Breast Neoplasms/*pathology
Cell Cycle Proteins/*genetics
Spinal Neoplasms/*genetics
Spinal Neoplasms/*secondary
Biomarkers, Tumor/genetics ; Breast Neoplasms/mortality ; Cluster Analysis ; Computational Biology ; Databases, Genetic ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Kaplan-Meier Estimate ; Protein Interaction Maps/genetics ; Spinal Neoplasms/mortality ; Triple Negative Breast Neoplasms/genetics ; Triple Negative Breast Neoplasms/mortality ; Triple Negative Breast Neoplasms/pathology ; Up-Regulation
Czasopismo naukowe
Tytuł :
Capecitabine for hormone receptor-positive versus hormone receptor-negative breast cancer.
Autorzy :
Hoon SN; Medical Oncology Department, St John of God Midland, Perth, Australia.; Medical Oncology Department, Sir Charles Gairdner Hospital, Perth, Australia.
Lau PK; Medical Oncology Department, Sir Charles Gairdner Hospital, Perth, Australia.; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Australia.
White AM; Murdoch Community Hospice, St John of God Hospital Murdoch, Perth, Australia.; Palliative Care Department, Royal Perth Hospital, Perth, Australia.
Bulsara MK; Institute for Health Research, University of Notre Dame Australia, Fremantle, Australia.; School of Population and Global Health, The University of Western Australia, Perth, Australia.; Division of Surgery and Interventional Science, University College London, London, UK.
Banks PD; Medical Oncology Department, Peter MacCallum Cancer Centre, Melbourne, Australia.; Medical Oncology Department, University Hospital Geelong, Geelong, Australia.
Redfern AD; School of Medicine, University of Western Australia, Perth, Australia.; Medical Oncology Department, Fiona Stanley Hospital, Perth, Australia.
Pokaż więcej
Źródło :
The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2021 May 26; Vol. 5. Cochrane AN: CD011220. Date of Electronic Publication: 2021 May 26.
Typ publikacji :
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Systematic Review
MeSH Terms :
Antimetabolites, Antineoplastic/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Capecitabine/*therapeutic use
Antimetabolites, Antineoplastic/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bias ; Breast Neoplasms/chemistry ; Breast Neoplasms/mortality ; Breast Neoplasms/pathology ; Capecitabine/adverse effects ; Chemotherapy, Adjuvant ; Disease-Free Survival ; Female ; Humans ; Neoadjuvant Therapy ; Quality of Life ; Randomized Controlled Trials as Topic ; Triple Negative Breast Neoplasms/drug therapy
Czasopismo naukowe
Tytuł :
Breast cancer during pregnancy: retrospective institutional case series.
Autorzy :
Matos E; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Ovcaricek T; Department of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.
Pokaż więcej
Źródło :
Radiology and oncology [Radiol Oncol] 2021 May 04; Vol. 55 (3), pp. 362-368. Date of Electronic Publication: 2021 May 04.
Typ publikacji :
Journal Article
MeSH Terms :
Guideline Adherence*
Breast Neoplasms/*therapy
Pregnancy Complications, Neoplastic/*therapy
Adult ; Antineoplastic Agents/therapeutic use ; Biopsy ; Biopsy, Large-Core Needle ; Breast/pathology ; Breast Neoplasms/diagnosis ; Breast Neoplasms/pathology ; Female ; Humans ; Mastectomy ; Pregnancy ; Pregnancy Complications, Neoplastic/diagnosis ; Pregnancy Complications, Neoplastic/pathology ; Pregnancy Trimesters ; Retrospective Studies ; Triple Negative Breast Neoplasms/therapy
Czasopismo naukowe
Tytuł :
[Patients treated with palbociclib and endocrine therapy for metastatic breast cancer: Can we predict the occurrence of severe early hematological toxicity?]
Autorzy :
Vazquez L; Sainte-Catherine Institute, 250, chemin des baigne-pieds, 84000 Avignon, France. Electronic address: .
Arnaud A; Sainte-Catherine Institute, 250, chemin des baigne-pieds, 84000 Avignon, France.
Grenier J; Sainte-Catherine Institute, 250, chemin des baigne-pieds, 84000 Avignon, France.
Debourdeau P; Sainte-Catherine Institute, 250, chemin des baigne-pieds, 84000 Avignon, France.
Pokaż więcej
Transliterated Title :
Patients sous palbociclib et hormonothérapie pour un cancer du sein métastatique : peut-on prédire la survenue d’une hématotoxicité précoce et sévère ?
Źródło :
Bulletin du cancer [Bull Cancer] 2021 May; Vol. 108 (5), pp. 544-552. Date of Electronic Publication: 2021 Apr 02.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Antineoplastic Agents/*adverse effects
Breast Neoplasms/*drug therapy
Piperazines/*adverse effects
Pyridines/*adverse effects
Thrombocytopenia/*chemically induced
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Breast Neoplasms/chemistry ; Breast Neoplasms/pathology ; Breast Neoplasms, Male/drug therapy ; Breast Neoplasms, Male/pathology ; Cyclin-Dependent Kinase 4/antagonists & inhibitors ; Cyclin-Dependent Kinase 6/antagonists & inhibitors ; Female ; Fulvestrant/adverse effects ; Fulvestrant/therapeutic use ; Humans ; Letrozole/therapeutic use ; Male ; Middle Aged ; Multivariate Analysis ; Neutropenia/chemically induced ; Piperazines/therapeutic use ; Progression-Free Survival ; Pyridines/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The breast cancer drug market.
Autorzy :
Wilcock P
Webster RM
Pokaż więcej
Źródło :
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2021 May; Vol. 20 (5), pp. 339-340.
Typ publikacji :
Wiadomości
MeSH Terms :
Antineoplastic Agents/*economics
Breast Neoplasms/*drug therapy
Breast Neoplasms/*economics
Health Care Sector/*economics
Health Care Sector/*trends
Female ; Humans ; Receptor, ErbB-2/drug effects ; Triple Negative Breast Neoplasms/drug therapy
Periodyk
Tytuł :
Male and female breast cancer: the two faces of the same genetic susceptibility coin.
Autorzy :
Silva SN; Center for Toxicogenomics and Human Health, NOVA Medical School, NMS, Universidade Nova de Lisboa, Rua Câmara Pestana, No.6, 1169-056, Lisbon, Portugal. .
Gomes BC; Center for Toxicogenomics and Human Health, NOVA Medical School, NMS, Universidade Nova de Lisboa, Rua Câmara Pestana, No.6, 1169-056, Lisbon, Portugal.
André S; Department of Pathology, Portuguese Institute of Oncology of Lisbon, 1099-023, Lisbon, Portugal.
Félix A; Department of Pathology, Portuguese Institute of Oncology of Lisbon, 1099-023, Lisbon, Portugal.; NOVA Medical School, Universidade Nova de Lisboa, 1169-056, Lisbon, Portugal.
Rodrigues AS; Center for Toxicogenomics and Human Health, NOVA Medical School, NMS, Universidade Nova de Lisboa, Rua Câmara Pestana, No.6, 1169-056, Lisbon, Portugal.
Rueff J; Center for Toxicogenomics and Human Health, NOVA Medical School, NMS, Universidade Nova de Lisboa, Rua Câmara Pestana, No.6, 1169-056, Lisbon, Portugal. .
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Jul; Vol. 188 (1), pp. 295-305. Date of Electronic Publication: 2021 May 03.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms, Male/*genetics
DNA Glycosylases/*genetics
Tumor Suppressor Protein p53/*genetics
X-ray Repair Cross Complementing Protein 1/*genetics
Breast Neoplasms ; Case-Control Studies ; Cohort Studies ; Female ; Genetic Predisposition to Disease ; Genotype ; Humans ; Male ; Polymorphism, Single Nucleotide
Czasopismo naukowe
Tytuł :
Clinical outcomes of platinum-based chemotherapy in patients with advanced breast cancer: An 11-year single institutional experience.
Autorzy :
Franzoi MA; Academic Trials Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Belgium. Electronic address: .
Saúde-Conde R; Medical Oncology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
Ferreira SC; Medical Oncology Department, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
Eiger D; Academic Trials Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Belgium.
Awada A; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Belgium.
de Azambuja E; Academic Trials Promoting Team, Institut Jules Bordet, Université Libre de Bruxelles (U.L.B), Belgium; Medical Oncology Clinic, Institut Jules Bordet, Université Libre de Bruxelles, Belgium.
Pokaż więcej
Źródło :
Breast (Edinburgh, Scotland) [Breast] 2021 Jun; Vol. 57, pp. 86-94. Date of Electronic Publication: 2021 Mar 23.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms/*drug therapy
Platinum/*therapeutic use
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Middle Aged ; Platinum/adverse effects ; Prognosis ; Receptor, ErbB-2 ; Retrospective Studies ; Superior Vena Cava Syndrome ; Survival Rate ; Treatment Outcome ; Triple Negative Breast Neoplasms/drug therapy
Czasopismo naukowe
Tytuł :
Breast cancer in the oldest old (≥ 89 years): Tumor characteristics, treatment choices, clinical outcomes and literature review.
Autorzy :
Di Lascio S; Oncology Institute of Southern Switzerland - IOSI, Bellinzona, Switzerland; CSSI, Centro di Senologia Della Svizzera Italiana, Ente Ospedaliero Cantonale - EOC, Switzerland. Electronic address: .
Tognazzo E; Gynecology and Obstetric Department, Ente Ospedaliero Cantonale - EOC, Lugano, Switzerland. Electronic address: .
Bigiotti S; Gynecology and Obstetric Department, Ente Ospedaliero Cantonale - EOC, Lugano, Switzerland.
Bonollo M; Gynecology and Obstetric Department, Ente Ospedaliero Cantonale - EOC, Lugano, Switzerland.
Costa A; CSSI, Centro di Senologia Della Svizzera Italiana, Ente Ospedaliero Cantonale - EOC, Switzerland; European School of Oncology - ESO, Milano, Italy.
Pagani O; European School of Oncology - ESO, Milano, Italy; Interdisciplinary Cancer Service, Hopital Riviera-Chablais, Rennaz, Vaud, Geneva University Hospitals, Switzerland.
Meani F; CSSI, Centro di Senologia Della Svizzera Italiana, Ente Ospedaliero Cantonale - EOC, Switzerland; Gynecology and Obstetric Department, Ente Ospedaliero Cantonale - EOC, Lugano, Switzerland.
Pokaż więcej
Źródło :
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2021 Apr; Vol. 47 (4), pp. 796-803. Date of Electronic Publication: 2020 Oct 13.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Breast Neoplasms/*pathology
Breast Neoplasms/*therapy
Carcinoma in Situ/*therapy
Carcinoma, Ductal, Breast/*therapy
Carcinoma, Lobular/*therapy
Neoplasm Recurrence, Local/*pathology
Aged, 80 and over ; Breast Neoplasms/diagnosis ; Breast Neoplasms/metabolism ; Breast Neoplasms, Male/diagnosis ; Breast Neoplasms, Male/pathology ; Breast Neoplasms, Male/surgery ; Carcinoma in Situ/diagnosis ; Carcinoma in Situ/metabolism ; Carcinoma in Situ/pathology ; Carcinoma, Ductal, Breast/diagnosis ; Carcinoma, Ductal, Breast/metabolism ; Carcinoma, Ductal, Breast/secondary ; Carcinoma, Lobular/diagnosis ; Carcinoma, Lobular/metabolism ; Carcinoma, Lobular/secondary ; Chemotherapy, Adjuvant ; Clinical Decision-Making ; Disease Progression ; Female ; Follow-Up Studies ; Humans ; Male ; Mastectomy ; Neoplasm Grading ; Neoplasm Invasiveness ; Neoplasm Metastasis ; Neoplasm Staging ; Radiotherapy, Adjuvant ; Receptor, ErbB-2/metabolism ; Receptors, Estrogen/metabolism ; Receptors, Progesterone/metabolism ; Retrospective Studies ; Survival Rate ; Triple Negative Breast Neoplasms/diagnosis ; Triple Negative Breast Neoplasms/pathology ; Triple Negative Breast Neoplasms/therapy
Czasopismo naukowe
Tytuł :
Dynamics of circulating tumor DNA during postoperative radiotherapy in patients with residual triple-negative breast cancer following neoadjuvant chemotherapy: a prospective observational study.
Autorzy :
Kim H; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-gu, Seoul, 06351, Republic of Korea. .
Kim YJ; Samsung Genome Institute, Samsung Medical Center, Seoul, South Korea.
Park D; Samsung Genome Institute, Samsung Medical Center, Seoul, South Korea.; GENINUS Inc, Seoul, South Korea.
Park WY; Samsung Genome Institute, Samsung Medical Center, Seoul, South Korea.; Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Suwon, South Korea.
Choi DH; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Park W; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Cho WK; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Kim N; Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-Ro, Gangnam-gu, Seoul, 06351, Republic of Korea.
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2021 Aug; Vol. 189 (1), pp. 167-175. Date of Electronic Publication: 2021 Jun 21.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Breast Neoplasms*
Circulating Tumor DNA*/genetics
Triple Negative Breast Neoplasms*/drug therapy
Triple Negative Breast Neoplasms*/genetics
Biomarkers, Tumor/genetics ; Female ; Humans ; Mutation ; Neoadjuvant Therapy ; Neoplasm Recurrence, Local
Czasopismo naukowe
Tytuł :
[Breast cancer - state of the art - Short overview of the current standard of treatment].
Autorzy :
Albert A
Stüber T
Bauer J
Wöckel A
Pokaż więcej
Transliterated Title :
Was ist neu bei der Diagnostik und Therapie des Mammakarzinoms? – Aktuelle Standards in der Behandlung von Brustkrebs.
Źródło :
Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 2020 Oct; Vol. 145 (20), pp. 1460-1463. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/diagnosis
Breast Neoplasms*/genetics
Breast Neoplasms*/therapy
Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor/genetics ; Breast/diagnostic imaging ; Breast/surgery ; Breast Neoplasms, Male ; Early Detection of Cancer ; Estrogen Receptor alpha/genetics ; Female ; Humans ; Male ; Mastectomy ; Middle Aged
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies